Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is looking at whether a hydration intervention can reduce side effects from GLP-1 medications like semaglutide or tirzepatide — do you think dehydration is a concern for me specifically given my current health status, and would something like this be worth exploring?
2. 2Since this trial is listed as Phase NA and is primarily measuring whether the hydration approach is acceptable and feasible rather than proving it works, what does that mean for what I could realistically expect to learn or gain from participating?
3. 3The trial is tracking both a physiological hydration score and how hydrated I feel personally — how are those two things measured, and would participating require any tests or check-ins that might be difficult to fit into my routine?
4. 4Given that this study focuses on managing side effects rather than treating my obesity or diabetes directly, should I be thinking about this alongside standard treatment, or is there a reason to prioritize one path over the other right now?
5. 5Are there any risks specific to a structured hydration protocol that I should be aware of, especially if I have any kidney issues or take medications that affect fluid balance?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.